Home
Browse
Search
Statistics
About
Usage
PMID: 24083983
Loo TW, Clarke DM
Drug rescue distinguishes between different structural models of human P-glycoprotein.
Biochemistry. 2013 Oct 15;52(41):7167-9. doi: 10.1021/bi401269m. Epub 2013 Oct 2.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
13
ABCB1 p.Ile306Cys
X
ABCB1 p.Ile306Cys 24083983:13:34
status:
NEW
view ABCB1 p.Ile306Cys details
It was found that labeling of the
I306C
mutant with a thiol-reactive derivative of the substrate verapamil activated ATPase activity ~8-fold12 and labeling was blocked by verapamil.
Login to comment
14
ABCB1 p.Ile306Arg
X
ABCB1 p.Ile306Arg 24083983:14:35
status:
NEW
view ABCB1 p.Ile306Arg details
In addition, it was found that the
I306R
mutation inhibited binding of a subset of P-gp drug substrates.13 These results suggest that residue Ile306 is important for binding of drug substrates and activation of Received: September 12, 2013 Revised: September 29, 2013 Published: October 1, 2013 Figure 1.
Login to comment
15
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:15:27
status:
NEW
view ABCB1 p.Gly251Val details
Drug rescue of TM5 and TM9
G251V
P-gp arginine mutants.
Login to comment
18
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:18:100
status:
NEW
view ABCB1 p.Gly251Val details
An asterisk indicates a significant difference from the amount of the mature form observed when the
G251V
parent was expressed without cyclosporine A (~5% mature).
Login to comment
23
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:23:90
status:
NEW
view ABCB1 p.Gly251Val details
Accordingly, the ability of drug substrates to promote maturation of a processing mutant (
G251V
) containing an arginine at each position in TM5 was used to map the locations of residues that faced the lipid bilayer (would prevent rescue) or the aqueous channel (would be rescued).
Login to comment
24
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:24:135
status:
NEW
view ABCB1 p.Gly251Val details
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:24:149
status:
NEW
view ABCB1 p.Gly251Val details
The rationale for using this assay was that drug substrates such as cyclosporine A can promote maturation of a P-gp processing mutant (
G251V
).14 The
G251V
mutation is located in the second intracellular loop (ICL2) (Figure 1A) and appears to trap P-gp in a partially folded conformation as a 150 kDa core-glycosylated protein.
Login to comment
25
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:25:55
status:
NEW
view ABCB1 p.Gly251Val details
Expression in the presence of a drug substrate induces
G251V
to complete the folding process to yield an active mature 170 kDa protein.15 Introduction of an arginine onto the lipid face of TM5 would inhibit drug rescue.
Login to comment
27
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:27:27
status:
NEW
view ABCB1 p.Gly251Val details
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:27:49
status:
NEW
view ABCB1 p.Gly251Val details
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:27:65
status:
NEW
view ABCB1 p.Gly251Val details
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:27:124
status:
NEW
view ABCB1 p.Gly251Val details
ABCB1 p.Ser298Arg
X
ABCB1 p.Ser298Arg 24083983:27:71
status:
NEW
view ABCB1 p.Ser298Arg details
ABCB1 p.Ile297Arg
X
ABCB1 p.Ile297Arg 24083983:27:55
status:
NEW
view ABCB1 p.Ile297Arg details
Examples of drug rescue of
G251V
and TM5 mutants
G251V
/
I297R
and
G251V
/
S298R
are shown in Figure 1B. When processing mutant
G251V
is expressed in the absence of cyclosporine A, the major product was the immature 150 kDa protein (~95% of total P-gp).
Login to comment
29
ABCB1 p.Ser298Arg
X
ABCB1 p.Ser298Arg 24083983:29:7
status:
NEW
view ABCB1 p.Ser298Arg details
ABCB1 p.Ile297Arg
X
ABCB1 p.Ile297Arg 24083983:29:21
status:
NEW
view ABCB1 p.Ile297Arg details
Mutant
S298R
but not
I297R
could be rescued by cyclosporine A.
Login to comment
30
ABCB1 p.Gly251Val
X
ABCB1 p.Gly251Val 24083983:30:80
status:
NEW
view ABCB1 p.Gly251Val details
Arginine mutations were then introduced into each position of TM5 or TM9 in the
G251V
background.
Login to comment